| Weaker 1Q for AMAG - Morningstar.com |
|
|
Morningstar.comAMAG reported roughly 1700 providers have now purchased the therapeutic, with 60% of demand coming from outside the dialysis setting. ...Canaccord Adams Reiterates a 'Buy' on AMAG Pharmaceuticals (AMAG ... read more |